170 related articles for article (PubMed ID: 15890684)
1. Conditional overexpression of transgenes in megakaryocytes and platelets in vivo.
Nguyen HG; Yu G; Makitalo M; Yang D; Xie HX; Jones MR; Ravid K
Blood; 2005 Sep; 106(5):1559-64. PubMed ID: 15890684
[TBL] [Abstract][Full Text] [Related]
2. Transgenic, inducible RNAi in megakaryocytes and platelets in mice.
Takiguchi M; James C; Josefsson EC; Carmichael CL; Premsrirut PK; Lowe SW; Hamilton JR; Huang DC; Kile BT; Dickins RA
J Thromb Haemost; 2010 Dec; 8(12):2751-6. PubMed ID: 21138522
[TBL] [Abstract][Full Text] [Related]
3. Generation dependent reduction of tTA expression in double transgenic NZL-2/tTA(CMV) mice.
Fedorov LM; Tyrsin OY; Sakk O; Ganscher A; Rapp UR
Genesis; 2001 Oct; 31(2):78-84. PubMed ID: 11668682
[TBL] [Abstract][Full Text] [Related]
4. Targeting expression to megakaryocytes and platelets by lineage-specific lentiviral vectors.
Latorre-Rey LJ; Wintterle S; Dütting S; Kohlscheen S; Abel T; Schenk F; Wingert S; Rieger MA; Nieswandt B; Heinz N; Modlich U
J Thromb Haemost; 2017 Feb; 15(2):341-355. PubMed ID: 27930847
[TBL] [Abstract][Full Text] [Related]
5. In vivo expression of a conditional TGF-beta1 transgene: no evidence for TGF-beta1 transgene expression in SM22alpha-tTA transgenic mice.
Lee S; Agah R; Xiao M; Frutkin AD; Kremen M; Shi H; Dichek DA
J Mol Cell Cardiol; 2006 Jan; 40(1):148-56. PubMed ID: 16288910
[TBL] [Abstract][Full Text] [Related]
6. The
Nagy Z; Vögtle T; Geer MJ; Mori J; Heising S; Di Nunzio G; Gareus R; Tarakhovsky A; Weiss A; Neel BG; Desanti GE; Mazharian A; Senis YA
Blood; 2019 Jan; 133(4):331-343. PubMed ID: 30429161
[TBL] [Abstract][Full Text] [Related]
7. Selective targeting of gene products with the megakaryocyte platelet factor 4 promoter.
Ravid K; Beeler DL; Rabin MS; Ruley HE; Rosenberg RD
Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1521-5. PubMed ID: 1899930
[TBL] [Abstract][Full Text] [Related]
8. Aberrant quantity and localization of Aurora-B/AIM-1 and survivin during megakaryocyte polyploidization and the consequences of Aurora-B/AIM-1-deregulated expression.
Zhang Y; Nagata Y; Yu G; Nguyen HG; Jones MR; Toselli P; Jackson CW; Tatsuka M; Todokoro K; Ravid K
Blood; 2004 May; 103(10):3717-26. PubMed ID: 14751927
[TBL] [Abstract][Full Text] [Related]
9. Survivin overexpression alone does not alter megakaryocyte ploidy nor interfere with erythroid/megakaryocytic lineage development in transgenic mice.
McCrann DJ; Yezefski T; Nguyen HG; Papadantonakis N; Liu H; Wen Q; Crispino JD; Ravid K
Blood; 2008 Apr; 111(8):4092-5. PubMed ID: 18245663
[TBL] [Abstract][Full Text] [Related]
10. Conditional transgene expression in endothelial cells.
Sarao R; Dumont DJ
Transgenic Res; 1998 Nov; 7(6):421-7. PubMed ID: 10341450
[TBL] [Abstract][Full Text] [Related]
11. Conditional gene expression in the epidermis of transgenic mice using the tetracycline-regulated transactivators tTA and rTA linked to the keratin 5 promoter.
Diamond I; Owolabi T; Marco M; Lam C; Glick A
J Invest Dermatol; 2000 Nov; 115(5):788-94. PubMed ID: 11069615
[TBL] [Abstract][Full Text] [Related]
12. Tetracycline inducible gene manipulation in serotonergic neurons.
Weber T; Renzland I; Baur M; Mönks S; Herrmann E; Huppert V; Nürnberg F; Schönig K; Bartsch D
PLoS One; 2012; 7(5):e38193. PubMed ID: 22693598
[TBL] [Abstract][Full Text] [Related]
13. Enhancing functional platelet release in vivo from in vitro-grown megakaryocytes using small molecule inhibitors.
Jarocha D; Vo KK; Lyde RB; Hayes V; Camire RM; Poncz M
Blood Adv; 2018 Mar; 2(6):597-606. PubMed ID: 29545255
[TBL] [Abstract][Full Text] [Related]
14. Developing tTA transgenic rats for inducible and reversible gene expression.
Zhou H; Huang C; Yang M; Landel CP; Xia PY; Liu YJ; Xia XG
Int J Biol Sci; 2009; 5(2):171-81. PubMed ID: 19214245
[TBL] [Abstract][Full Text] [Related]
15. Xenobiotic response in humanized double transgenic mice expressing tetracycline-controlled transactivator and human CYP1B1.
Hwang DY; Chae KR; Shin DH; Hwang JH; Lim CH; Kim YJ; Kim BJ; Goo JS; Shin YY; Jang IS; Cho JS; Kim YK
Arch Biochem Biophys; 2001 Nov; 395(1):32-40. PubMed ID: 11673863
[TBL] [Abstract][Full Text] [Related]
16. C3G transgenic mouse models with specific expression in platelets reveal a new role for C3G in platelet clotting through its GEF activity.
Gutiérrez-Herrero S; Maia V; Gutiérrez-Berzal J; Calzada N; Sanz M; González-Manchón C; Pericacho M; Ortiz-Rivero S; González-Porras JR; Arechederra M; Porras A; Guerrero C
Biochim Biophys Acta; 2012 Aug; 1823(8):1366-77. PubMed ID: 22659131
[TBL] [Abstract][Full Text] [Related]
17. A novel doxycycline-inducible system for the transgenic analysis of mammary gland biology.
Gunther EJ; Belka GK; Wertheim GB; Wang J; Hartman JL; Boxer RB; Chodosh LA
FASEB J; 2002 Mar; 16(3):283-92. PubMed ID: 11874978
[TBL] [Abstract][Full Text] [Related]
18. Pf4-Cre transgenic mice allow the generation of lineage-restricted gene knockouts for studying megakaryocyte and platelet function in vivo.
Tiedt R; Schomber T; Hao-Shen H; Skoda RC
Blood; 2007 Feb; 109(4):1503-6. PubMed ID: 17032923
[TBL] [Abstract][Full Text] [Related]
19. An efficient system for tissue-specific overexpression of transgenes in podocytes in vivo.
Moeller MJ; Soofi A; Sanden S; Floege J; Kriz W; Holzman LB
Am J Physiol Renal Physiol; 2005 Aug; 289(2):F481-8. PubMed ID: 15784842
[TBL] [Abstract][Full Text] [Related]
20. -245 bp of 5'-flanking region from the human platelet factor 4 gene is sufficient to drive megakaryocyte-specific expression in vivo.
Cui Z; Reilly MP; Surrey S; Schwartz E; McKenzie SE
Blood; 1998 Apr; 91(7):2326-33. PubMed ID: 9516130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
